n-(6-aminohexyl)-1-naphthalenesulfonamide has been researched along with Asthma in 1 studies
N-(6-aminohexyl)-1-naphthalenesulfonamide: calmodulin antagonist; RN given refers to parent cpd
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morita, Y | 1 |
| Miyamoto, T | 1 |
1 other study available for n-(6-aminohexyl)-1-naphthalenesulfonamide and Asthma
| Article | Year |
|---|---|
[Calmodulin antagonists inhibit histamine release from human basophils].
Topics: Asthma; Basophils; Calmodulin; Histamine Release; Humans; Sulfonamides | 1984 |